Information regarding the Company’s significant accounting policies is contained in Note 2, “Summary of significant accounting policies,” to the financial statements in the Company’s Annual Report on Form 10-K for the year ended February 2, 2013. Presented below in this and the following notes is supplemental information that should be read in conjunction with “Notes to Financial Statements” in the Annual Report.

Fiscal quarter

The Company’s quarterly periods are the 13 weeks ending on the Saturday closest to April 30, July 31, October 31, and January 31. The Company’s third quarters in fiscal 2013 and 2012 ended on November 2, 2013 and October 27, 2012, respectively.

Share-based compensation

The Company measures share-based compensation cost on the grant date, based on the fair value of the award, and recognizes the expense over the requisite service period for awards expected to vest. The Company estimated the grant date fair value of stock options using a Black-Scholes valuation model using the following weighted-average assumptions for the periods indicated:

During the quarter the Company made changes to update valuation assumptions to Company specific information for expected life and volatility. These changes are reflected in the current quarter in the table above and had no material impact on the calculation.

The Company granted 286 and 213 stock options during the 39 weeks ended November 2, 2013 and October 27, 2012, respectively. The compensation cost that has been charged against operating income was $2,167 and $2,937 for the 13 weeks ended November 2, 2013 and October 27, 2012, respectively. The compensation cost that has been charged against operating income was $7,804 and $8,799 for the 39 weeks ended November 2, 2013 and October 27, 2012, respectively. The weighted-average grant date fair value of these options was $36.77 and $45.84, respectively. At November 2, 2013, there was approximately $20,513 of unrecognized compensation expense related to unvested options.

The Company issued 139 and 58 restricted stock awards during 39 weeks ended November 2, 2013 and October 27, 2012, respectively. The compensation cost that has been charged against operating income was $2,230 and $438 for the 13 weeks ended November 2, 2013 and October 27, 2012, respectively. The compensation cost that has been charged against operating income was $4,132 and $922 for the 39 weeks ended November 2, 2013 and October 27, 2012, respectively. At November 2, 2013, there was approximately $10,758 of unrecognized compensation expense related to restricted stock awards.